Research Silos in Cancer Disparities: Obstacles to Improving Clinical Outcomes for Underserved Patient Populations

Area of Science:

• Oncology
• Health Disparities Research
• Translational Medicine

Background:

• Significant racial disparities persist in cancer outcomes, with non-White patients experiencing worse results compared to White patients.
• Underrepresentation of non-White populations in clinical trials and research datasets contributes to these disparities.
• Existing research often operates in silos, focusing separately on socioeconomic factors linked to racism and genetic ancestry's molecular impact.

Purpose of the Study:

• To advocate for breaking down research silos in cancer disparities.
• To promote an integrated understanding of how race and racism influence cancer development and outcomes.
• To foster the development of equitable precision medicine and cancer therapeutics.

Main Methods:

• This perspective reviews existing literature on racial disparities in cancer research.
• It analyzes the limitations of siloed research approaches (socioeconomic vs. genetic).
• It proposes an integrated framework for future cancer disparities research.

Main Results:

• Current research paradigms inadequately address the multifaceted impact of race and racism on cancer.
• Siloed approaches limit the development of universally applicable diagnostics and therapeutics.
• An integrated approach is crucial for understanding the molecular biology of cancer influenced by stress and environment.

Conclusions:

• Breaking down research silos is essential for achieving health equity in cancer care.
• An integrated understanding of socioeconomic and genetic factors will accelerate progress in precision medicine.
• This comprehensive approach will lead to improved cancer diagnostics and therapeutics for diverse patient populations.